Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-838-9 | CAS number: 75-09-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- A physiological pharmacokinetic model for dermal absorption of vapors in the rat
- Author:
- McDougal JN, Jepson GW, Clewel III HJ, MacNaughton MG, Andersen ME
- Year:
- 1 986
- Bibliographic source:
- Toxicol Appl Pharmacol 85: 286-294
Materials and methods
- Principles of method if other than guideline:
- Rats were exposed for 4 h by inhalation, and DCM was measured in blood samples. The total amount DCM absorbed through the skin during the exposure was calculated based on blood concentrations during and at the end of the exposure using a physiological model (Andersen et al., 1984).
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Dichloromethane
- EC Number:
- 200-838-9
- EC Name:
- Dichloromethane
- Cas Number:
- 75-09-2
- Molecular formula:
- CH2Cl2
- IUPAC Name:
- dichloromethane
- Test material form:
- not specified
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Male Fischer 344 rats (190 to 230 g) were used for all experiments. Surgical implantation ofindwellingjugular cannulas and clipping of the fur were accomplished under ketamine/xylazine anesthesia 24 hr prior to exposure.
Administration / exposure
- Type of coverage:
- other: vapor exposure
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 4 h
- Doses:
- Concentrations were: 30000, 60000 and 100000 ppm (106, 212, and 353 g/m3).
- No. of animals per group:
- 6
- Control animals:
- no
- Details on study design:
- A specially designed dermal vapor absorption chamber prevented inhalation of vapor by providing clean filtered breathing air through a latex face mask. Design and operation of this chamber as well as blood concentrations measured during exposures were described previously (McDougal et al., 1985). On the day ofthe exposures, six rats were placed in the chamber and exposed for 4 h. Blood samples (0.1 ml) were collected before and during the DCM vapor exposures via the indwelling jugular cannula, extracted with heptane, and analyzed for DCM with electron capture detection after gas chromatographic separation.
Results and discussion
- Signs and symptoms of toxicity:
- not specified
- Dermal irritation:
- not specified
- Absorption in different matrices:
- Measured DCM blood concentrations increased with an increase in exposure concentration (Fig. 2). Blood concentrations rose rapidly and were nearly at steady state at 1 hr in all but the 100,000-ppm exposure, which took longer. Blood concentrations at the
higher exposure concentrations were greater than expected based on the 30,000-ppm exposure.
The amount and rate of penetration of vapors through the skin was proportional to exposure concentration (Fig. 3). Mean permeability constant was 0.28 cm/h.
Predictions from the skin exposure model were in good agreement with the DCM exposure concentrations (Fig. 3). Calculated flux data are indicated in Table 4 and are proportional to concentration. - Total recovery:
- Not applicable
Percutaneous absorptionopen allclose all
- Time point:
- 4 h
- Dose:
- 30000 ppm
- Parameter:
- rate
- Absorption:
- 0.031 mg cm-2 h-1
- Time point:
- 4 h
- Dose:
- 60000 ppm
- Parameter:
- rate
- Absorption:
- 0.052 mg cm-2 h-1
- Time point:
- 4 h
- Dose:
- 100000 ppm
- Parameter:
- rate
- Absorption:
- 0.103 mg cm-2 h-1
- Time point:
- 4 h
- Dose:
- 30000, 60000, 100000 ppm
- Parameter:
- other: mean permeability constant
- Absorption:
- 0.28 cm/h
Applicant's summary and conclusion
- Conclusions:
- The vapour absorption rate of DCM in rats during exposure at 30000, 60000 or 100000 ppm (106, 212 or 353 g/m3) was 0.031, 0.052 and 0.103 mg/cm2/h, respectively. The mean permeability constant was 0.28 cm/h.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.